Viropharma
Shire delivers record revenues
February 16, 2015Sales and Marketing ADHD, AbbVie, Shire, Viropharma, Vyvanse, intuniv, lialda
Shire has posted strong growth in its full-year results, showing that the company is faring well even after the collapse …
Shire spends $4.2 billion on ViroPharma purchase
November 11, 2013Sales and Marketing Cinryze, Firazyr, Shire, Viropharma
Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …
EMA grants first paediatric use marketing authorisation
September 9, 2011Sales and Marketing Buccolam, PUMA, Viropharma, paediatric trials, seizures
The first children’s medicine to hold a new paediatric use marketing authorisation (PUMA), making it available for children only, has …
FDA rejects Viropharma’s Cinryze manufacturing expansion
October 25, 2010Sales and Marketing Cinryze, FDA, FDA complete response letter, Viropharma, angioedema, pharmaceutical manufacturing
ViroPharma was dealt a blow late last week when the FDA turned down its application for additional manufacturing capacity for …
Pharma manufacturing news in brief
July 6, 2010Manufacturing and Production BMS, Borregaard Synthesis, Colorcon, JHP Pharma, Saltigo, Sanofi-Aventis, Synthetech, Viropharma, univar
New capital investments from Sanofi-Aventis, Bristol-Myers Squibb, Viropharma and Colorcon head up this round-up of developments in the pharmaceutical manufacturing …
